Capex / expansionFiled on BSE ·
Aarti Industries Commissions Phase I of Zone IV Manufacturing Facility
Aarti Industries · Chemicals & Petrochemicals
What the filing says
- Phase I of Zone IV project at Jhagadia, Gujarat commissioned, including Calcium Chloride, PEDA, and part of Multipurpose Plant.
- Zone IV platform enables downstream integration, diverse applications, and flexible manufacturing for high-value and niche products, some made in India first time.
- Aarti Industries is a global speciality chemicals company with 16 manufacturing plants, 4 R&D centers, 250+ scientists, founded in 1984.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue: Rank 1Margin: Rank 1
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Aarti Industries
- Board / shareholder meeting outcomeAarti Industries Limited announces voting results from 43rd AGM held on Sept 21, 2026
Other capex / expansion filings this fortnight
- Capex / expansionEverest Kanto Cylinder LtdEverest Kanto Cylinder Ltd subsidiary starts commercial production in Egypt
- Capex / expansionJuniper GreenJuniper Green Energy commissions additional 100.64 MWh BESS capacity
- Capex / expansionThe Ramco Cements LtdThe Ramco Cements Limited completes capacity enhancement at Jayanthipuram works
- Capex / expansionDeepak NitriteDeepak Chem Tech commissions chlorination and specialty chemical plant on 29 Sept 2026
- Capex / expansionNavin Fluo.Intl.Navin Fluorine commissions debottlenecked capacity at Dahej Multi Purpose Plant
- Capex / expansionNTPC Green Energy LtdNTPC Green Energy declares commercial operation of Kalasar Solar Energy Project capacity
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.